Human EGF R & (SRE-Luc) HEK293 Reporter Cell

IP Friendly
1/7
+4 View all
Cat. No. / Size
Price
Availability
Qty
CHEK-ATF278-2Vials (1Vial X 2)
$15,220.00
In Stock - Delivery in 2-3 weeks
CHEK-ATF278
Sub-Total :
$ 0
0
Add to Cart
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
0
Add to Cart
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Advantages
  • Genetically modified cell lines best reflect MOA (Mechanism of Action)
  • Higher activity and larger assay window for robust and reproducible cell-based bioassay
  • Comprehensive application data to support assay development and validation
  • Full tracible record, stringent quality control and validated cell passage stability
  • Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
  • Global commercial license assistance whenever regulatory filing is required
Description

The Human EGF R & (SRE-Luc) HEK293 Reporter Cell expressing human EGF R was engineered to express signaling response element driving luciferase expressing systems. When stimulated with human EGF protein, the EGF/EGF R interaction drives SRE-mediated luminescence. Inhibition of biological effect of the ligand-receptor interaction by corresponding antibody or small molecule inhibitor results in a decrease in luminescence.

Application

• Screen for anti-human EGF R or anti-human EGF neutralizing antibody.

• Screen for human EGF R small molecule inhibitor

EGFR Assay Principles

Growth Properties

Adherent

Selection Marker

Puromycin (2 μg/mL)

Complete Growth Medium

DMEM medium + 10% FBS

Freeze Medium

Serum-free cell cryopreservation medium

Quantity

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

Storage

Frozen in liquid nitrogen.

Mycoplasma Testing

Negative

Sterility Testing

Negative

Instructions for Use

See data sheet for detailed culturing and assay protocol.

ACRO Scientific Leadership Award

Supporting the scientists driving cell & gene therapy forward

Apply Now